Cargando…
Identification and Analysis of Estrogen Receptor α Promoting Tamoxifen Resistance-Related lncRNAs
70-75% breast cancer patients are estrogen receptor alpha positive (ERα+), and the antiestrogen drug tamoxifen has been used for the past three decades. However, in 20-30% of these patients, tamoxifen therapy fails due to intrinsic or acquired resistance. A previous study has showed ERα signaling st...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204353/ https://www.ncbi.nlm.nih.gov/pubmed/32420379 http://dx.doi.org/10.1155/2020/9031723 |